Repadax 2

Product Description

Repadax 2 contains Repaglinide (2 mg) a rapid-acting oral hypoglycemic agent designed to manage blood sugar levels in individuals with type 2 diabetes. By stimulating the pancreas to release insulin after meals Repaglinide helps control postprandial blood glucose spikes. This formulation is ideal for patients seeking effective management of their diabetes particularly those who require flexibility in their meal timing.